In the BioHarmony Drug Report Database

"Preview" Icon

Oritavancin

Kimyrsa, Orbactiv, Tenkasi (oritavancin) is an unknown pharmaceutical. Oritavancin was first approved as Kimyrsa on 2014-08-06. It is used to treat bacterial infections, infectious skin diseases, staphylococcal infections, and streptococcal infections in the USA. It has been approved in Europe to treat bacterial skin diseases and soft tissue infections. Orbactiv’s patents are valid until 2035-07-16 (FDA).

 

Trade Name

 

Orbactiv, Tenkasi
 

Common Name

 

oritavancin
 

ChEMBL ID

 

CHEMBL1688530
 

Indication

 

bacterial infections, bacterial skin diseases, infectious skin diseases, soft tissue infections, staphylococcal infections, streptococcal infections
 

Drug Class

 

Vancomycin-related compounds

Image (chem structure or protein)

Oritavancin structure rendering